YE Xuanting, LIU Lingshuang, JIANG Yi, et al. Effects of Fuzheng Jiedu Granules on immune function and life quality of patients with non-small cell lung cancer during postoperative chemotherapy. [J]. Shanghai Journal of Traditional Chinese Medicine 54(10):57-61(2020)
DOI:
YE Xuanting, LIU Lingshuang, JIANG Yi, et al. Effects of Fuzheng Jiedu Granules on immune function and life quality of patients with non-small cell lung cancer during postoperative chemotherapy. [J]. Shanghai Journal of Traditional Chinese Medicine 54(10):57-61(2020) DOI: 10.16305/j.1007-1334.2020.1908176.
Effects of Fuzheng Jiedu Granules on immune function and life quality of patients with non-small cell lung cancer during postoperative chemotherapy
Objective:To observe the effects of Fuzheng Jiedu Granules on immune function and quality of life of patients with non-small cell lung cancer (NSCLC) during postoperative chemotherapy. MethodsIt’s a prospective randomized controlled study in which 80 patients after radical resection of stage IB ~IIIA NSCLC were randomly divided into treatment group and control group, 40 cases in each group. The control group was treated with adjuvant chemotherapy combined with placebo, while the treatment group was treated with adjuvant chemotherapy combined with Fuzheng Jiedu Granules. After 4 cycles of chemotherapy, the immune function (CD3,+,、CD4,+,、CD8,+,、CD4,+,/CD8,+, NK cells), and quality of life scale (QLQ-C30, QLQ-LC13) within and between the two groups were compared. Results:①During the trial, 4 cases in the treatment group dropped out and were removed, while 3 cases in the control group dropped out and were removed. In total, 73 cases finally completed the trial, including 36 cases in the treatment group and 37 cases in the control group. ②The improvement rate of CD4,+, T cells in the treatment group and the control group was 50.0% and 24.3% respectively, and the improvement rate of CD4,+, T cells in the treatment group was higher than that in the control group (P,<,0.05); The improvement stability rate of CD4,+,/CD8,+, in the treatment group and control group was 80.6% and 54.1% respectively, and the improvement stability rate of CD4,+,/CD8,+, in the treatment group was higher than that in the control group (P,<,0.05). ③The levels of CD3,+, T cells and CD4,+, T cells in the treatment group increased after treatment (P,<,0.05). In the control group, the levels of CD3,+, T cells and the CD8,+, T cells increased after treatment (P,<,0.05), and the levels of NK cells and CD4,+,/CD8,+, decreased after treatment (P,<,0.05). ④In the treatment group, the scores of physical function, emotional function and global health status in QLQ-C30 increased (P,<,0.05), while the scores of cognitive function, fatigue and insomnia decreased after treatment (P,<,0.05). In the control group, the physical function score increased (P,<,0.05) and the cognitive function score decreased after treatment (P,<,0.05). After treatment, there were significant differences in global health status and fatigue score between two groups (P,<,0.05). ⑤The cough score in the QLQ-LC13 in the treatment group decreased after treatment (P,<,0.05), while there was no significant difference in the scores of the control group compared before and after treatment (P,>,0.05). After treatment, there was no significant difference in the scores of QLQ-LC13 between two groups (P,>,0.05). Conclusion:During the adjuvant chemotherapy after radical operation for NSCLC patients, the application of Fuzheng Jiedu Granules based on syndrome differentiation and the theory of “reinforcing healthy-qi and treating cancer” can help regulate the immune function of the body, improve fatigue and overall health status of patients, and further improve their quality of life.
关键词
非小细胞肺癌术后辅助化疗扶正解毒颗粒免疫功能生活质量
Keywords
non-small cell lung cancerpostoperationadjuvant chemotherapyFuzheng Jiedu Granulesimmune functionquality of life
Effect of Chinese herbal medicine combined with chemotherapy on tongue image changes in patients with early non-small cell lung cancer
Xuanhushangtong Tablets combined with celecoxib in promoting rapid rehabilitation after distal radius fractures
Propensity score matching analysis of the effect of the Yiqi Yangjing Prescription on the survival prognosis of patients with stage Ⅰ⁃ⅢA lung adenocarcinoma after surgery
Staged rehabilitation treatment strategy of traditional Chinese medicine after non⁃small cell lung cancer surgery
Current status of research on traditional Chinese medicine improving acquired resistance to EGFR⁃TKIs in patients with non⁃small cell lung cancer and analysis of TCM pathogenesis
Related Author
No data
Related Institution
Tumor Institute of Traditional Chinese Medicine, Shanghai Academy of Traditional Chinese Medicine
Department I of Oncology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Institute of Clinical Immunology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Sichuan Province Orthopaecological Hospital
Department of Oncology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University School of Medicine